13F Holdings
中文EN

ASBP Aspire-Lakewood Holdings, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1847345 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY41.6%
TTM EPS YoY201.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin-25.0%
Operating margin-7,494.8%
Net margin-11,314.1%
FCF margin—
EBITDA margin—

Returns

ROE-1,032.1%
ROA-152.1%
ROIC (approx.)—
Asset turnover0.01x

Leverage & solvency

Liabilities / assets13.2%
Debt / equity0.00x
Current ratio7.99x
Interest coverage-0.79x

Cash quality & payout

Operating cash flow / net income0.65x
Accruals ratio-53.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31
Income statement
Revenue$6,202———
Cost of revenue$6,318———
Gross profit-$116———
R&D expense$923,914$144,356——
SG&A expense$17.64M$940,421$1.34M$976,345
Operating income-$19.35M-$1.21M——
Interest expense$8.53M$97,988$8,966—
Pretax income-$24.48M-$1.31M——
Income tax—$1,013——
Net income-$24.48M-$1.31M$4.46M$3.34M
EPS (diluted)-16.38-1.90——
Weighted avg. shares (diluted)1.49M689,913——
Balance sheet
Cash & equivalents$1.00M$3,633$11,174$497,259
Inventory$253,160———
Current assets$1.31M$147,989$81,223$1.10M
Total assets$1.31M$147,989$19.98M$300.18M
Current liabilities$7.59M$1.69M$403,328$303,323
Total liabilities$7.69M$1.69M$403,328$11.12M
Shareholders' equity-$6.38M-$1.54M-$487,861-$9.94M
Shares outstanding117,780690,044——
Cash flow statement
Operating cash flow-$4.92M-$265,186-$653,107-$1.41M
Investing cash flow—$13.78M$284.92M-$294.69M
Financing cash flow$5.92M$257,645-$284.76M$296.59M
Stock-based compensation$14.13M$0——
Share buybacks—$13.78M$284.92M—

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.